Meyer Handelman Company’s Zimmer Biomet ZBH Stock Holding History

Meyer Handelman Company’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.42M	Sell	15,759 -13,410	-46%	-$1.23M	0.04%	141
2025 Q4	$2.62M	Sell	29,169 -5,700	-16%	-$540K	0.08%	120
2025 Q3	$3.43M	Sell	34,869 -2,575	-7%	-$255K	0.11%	110
2025 Q2	$3.42M	Sell	37,444 -1,301	-3%	-$126K	0.11%	115
2025 Q1	$4.39M	Sell	38,745 -3,795	-9%	-$406K	0.15%	108
2024 Q4	$4.49M	Sell	42,540 -3,180	-7%	-$341K	0.16%	104
2024 Q3	$4.94M	Sell	45,720 -2,470	-5%	-$270K	0.17%	101
2024 Q2	$5.23M	Sell	48,190 -6,070	-11%	-$716K	0.18%	99
2024 Q1	$7.16M	Sell	54,260 -2,780	-5%	-$347K	0.25%	90
2023 Q4	$6.94M	Hold	57,040	–	–	0.27%	87
2023 Q3	$6.4M	Buy	57,040 +1,880	+3%	+$239K	0.26%	89
2023 Q2	$8.03M	Buy	55,160 +3,035	+6%	+$412K	0.32%	81
2023 Q1	$6.73M	Sell	52,125 -1,920	-4%	-$241K	0.28%	89
2022 Q4	$6.89M	Buy	54,045 +1,850	+4%	+$215K	0.29%	85
2022 Q3	$5.46M	Buy	52,195 +2,340	+5%	+$257K	0.25%	93
2022 Q2	$5.24M	Buy	49,855 +1,610	+3%	+$191K	0.22%	98
2022 Q1	$6.17M	Buy	48,245 +16,316	+51%	+$1.97M	0.24%	96
2021 Q4	$3.94M	Buy	31,929 +1,978	+7%	+$259K	0.15%	111
2021 Q3	$4.26M	Hold	29,951	–	–	0.17%	105
2021 Q2	$4.68M	Hold	29,951	–	–	0.18%	102
2021 Q1	$4.66M	Buy	29,951 +1,977	+7%	+$306K	0.19%	100
2020 Q4	$4.18M	Buy	27,974 +1,978	+8%	+$279K	0.19%	100
2020 Q3	$3.44M	Hold	25,996	–	–	0.17%	101
2020 Q2	$3.01M	Hold	25,996	–	–	0.16%	106
2020 Q1	$2.55M	Hold	25,996	–	–	0.16%	102
2019 Q4	$3.78M	Hold	25,996	–	–	0.18%	100
2019 Q3	$3.46M	Hold	25,996	–	–	0.18%	105
2019 Q2	$2.97M	Hold	25,996	–	–	0.15%	110
2019 Q1	$3.06M	Buy	25,996 +535	+2%	+$60.8K	0.16%	107
2018 Q4	$2.56M	Sell	25,461 -1,977	-7%	-$222K	0.15%	108
2018 Q3	$3.5M	Hold	27,438	–	–	0.17%	103
2018 Q2	$2.97M	Hold	27,438	–	–	0.15%	109
2018 Q1	$2.9M	Sell	27,438 -2,794	-9%	-$324K	0.15%	114
2017 Q4	$3.54M	Sell	30,232 -222	-0.7%	-$25.1K	0.17%	110
2017 Q3	$3.46M	Sell	30,454 -445	-1%	-$51.4K	0.16%	109
2017 Q2	$3.85M	Hold	30,899	–	–	0.16%	105
2017 Q1	$3.66M	Hold	30,899	–	–	0.16%	106
2016 Q4	$3.1M	Hold	30,899	–	–	0.14%	111
2016 Q3	$3.9M	Hold	30,899	–	–	0.18%	102
2016 Q2	$3.61M	Hold	30,899	–	–	0.16%	104
2016 Q1	$3.2M	Hold	30,899	–	–	0.15%	109
2015 Q4	$3.08M	Hold	30,899	–	–	0.15%	110
2015 Q3	$2.82M	Sell	30,899 -206	-0.7%	-$20.7K	0.14%	111
2015 Q2	$3.3M	Hold	31,105	–	–	0.15%	109
2015 Q1	$3.55M	Hold	31,105	–	–	0.16%	104
2014 Q4	$3.42M	Hold	31,105	–	–	0.15%	106
2014 Q3	$3.04M	Sell	31,105 -552	-2%	-$54.3K	0.14%	106
2014 Q2	$3.19M	Hold	31,657	–	–	0.15%	104
2014 Q1	$2.91M	Hold	31,657	–	–	0.14%	106
2013 Q4	$2.86M	Hold	31,657	–	–	0.14%	108
2013 Q3	$2.52M	Hold	31,657	–	–	0.13%	108
2013 Q2	$2.3M	Buy	+31,657	New	+$2.37M	0.13%	109

Other funds holding ZBH

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Meyer Handelman Company's ZBH Position: Q1 2026 in Review

Meyer Handelman Company reduced its Zimmer Biomet (ZBH) stake by 46% in Q1 2026, selling an estimated $1.23M and leaving 15,759 shares worth $1.42M. The position accounts for 0.04% of the portfolio, ranked #141.

Meyer Handelman Company first reported a position in ZBH in Q2 2013 and has held it in 52 quarters since. The position peaked at $8.03M in Q2 2023. 912 funds tracked by Wall St. Rank hold ZBH as of Q1 2026.

Meyer Handelman Company held 15,759 shares of Zimmer Biomet worth $1.42M as of Q1 2026.
Meyer Handelman Company sold 13,410 Zimmer Biomet shares in Q1 2026, an estimated $1.23M.
Zimmer Biomet made up 0.04% of Meyer Handelman Company's portfolio in Q1 2026, its #141 holding.
Meyer Handelman Company first reported a position in Zimmer Biomet in Q2 2013 and has held it in 52 quarters since.
Meyer Handelman Company's Zimmer Biomet position peaked at $8.03M in Q2 2023.
912 funds tracked by Wall St. Rank held Zimmer Biomet as of Q1 2026.

Based on Meyer Handelman Company's 13F filing for Q1 2026, filed 20 Apr 2026.